On September 15, 2017 the Company issued 37,900,000 shares of Company common stock to satisfy the conversion of $9,437.10 of a convertible note payable with GHS Investments, LLC.
On September 22, 2017 the Company issued 39,800,000 shares of Company common stock to satisfy the conversion of $9,910.20 of a convertible note payable with GHS Investments, LLC.
8K as of Monday September 25, 2017 after the above described issuances OS is 838,879,628.
RCHA O/S 9/27/17 Wens. Close of business 838,879,628 No Change
Wow seriously? 90 whole million??????????? Oh wait what a relief it's only 90 million LOL.... Yes 90 whole million conversion for a great lotto ticket pharmaceutical stock. Thanks for pointing out the obvious.
$RCHA The total number of outstanding shares of common stock of the Company as of September 25, 2017 after the above described issuances is 838,879,628.